Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

Globally, cryptococcal meningitis is a leading cause of mortality among people with AIDS, despite the availability of effective amphotericin B–based therapy. In this trial in sub-Saharan Africa, the efficacy of two simpler treatment regimens was assessed.

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 378; no. 11; pp. 1004 - 1017
Main Authors Molloy, Síle F, Kanyama, Cecilia, Heyderman, Robert S, Loyse, Angela, Kouanfack, Charles, Chanda, Duncan, Mfinanga, Sayoki, Temfack, Elvis, Lakhi, Shabir, Lesikari, Sokoine, Chan, Adrienne K, Stone, Neil, Kalata, Newton, Karunaharan, Natasha, Gaskell, Kate, Peirse, Mary, Ellis, Jayne, Chawinga, Chimwemwe, Lontsi, Sandrine, Ndong, Jean-Gilbert, Bright, Philip, Lupiya, Duncan, Chen, Tao, Bradley, John, Adams, Jack, van der Horst, Charles, van Oosterhout, Joep J, Sini, Victor, Mapoure, Yacouba N, Mwaba, Peter, Bicanic, Tihana, Lalloo, David G, Wang, Duolao, Hosseinipour, Mina C, Lortholary, Olivier, Jaffar, Shabbar, Harrison, Thomas S
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 15.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Globally, cryptococcal meningitis is a leading cause of mortality among people with AIDS, despite the availability of effective amphotericin B–based therapy. In this trial in sub-Saharan Africa, the efficacy of two simpler treatment regimens was assessed.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1710922